A Phase I, Open-label Study of Absolute Bioavailability and Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]AZD9977 in Healthy Male Subjects
Latest Information Update: 12 Mar 2021
At a glance
- Drugs Balcinrenone (Primary) ; Balcinrenone (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 05 Mar 2021 Status changed from recruiting to completed.
- 31 Dec 2020 New trial record